AI Engines For more Details: Perplexity Kagi Labs You
Diuretic Effects: Amiloride is a potassium-sparing diuretic, which means it helps the body eliminate excess sodium and water while conserving potassium. It works by blocking the epithelial sodium channels (ENaC) in the distal tubules of the kidneys, reducing the reabsorption of sodium and water and increasing urine output.
Hypertension: Amiloride may be used alone or in combination with other antihypertensive medications to lower blood pressure in patients with hypertension. By promoting diuresis and reducing fluid volume, amiloride helps decrease blood pressure and improve cardiovascular outcomes.
Edema: Amiloride is also used to manage edema (fluid retention) associated with conditions such as congestive heart failure, cirrhosis of the liver, and nephrotic syndrome. By promoting diuresis without causing excessive potassium loss, amiloride helps reduce fluid buildup and alleviate symptoms of edema, such as swelling in the legs or abdomen.
Potassium-Sparing Properties: Unlike other diuretics, amiloride does not typically cause significant potassium loss. In fact, it helps conserve potassium by blocking sodium reabsorption in exchange for potassium excretion. This is particularly beneficial for patients at risk of hypokalemia (low potassium levels), such as those taking other diuretics or certain medications that increase potassium excretion.
Electrolyte Imbalance: While amiloride helps conserve potassium, it may also cause hyperkalemia (high potassium levels) in some patients, particularly those with impaired kidney function or other risk factors for electrolyte imbalance. Patients taking amiloride should have their electrolyte levels monitored regularly, especially potassium levels.
Renal Function: Amiloride is primarily excreted by the kidneys. Patients with renal impairment may require dosage adjustments or close monitoring during treatment with amiloride to prevent drug accumulation and potential adverse effects.
Hyponatremia: In rare cases, amiloride may cause hyponatremia (low sodium levels), particularly in patients with conditions that predispose them to sodium depletion or in those taking other medications that affect sodium balance. Patients should be monitored for signs and symptoms of hyponatremia, such as weakness, confusion, and seizures.
Drug Interactions: Amiloride may interact with other medications, including potassium supplements, potassium-sparing diuretics, ACE inhibitors, angiotensin II receptor blockers (ARBs), nonsteroidal anti-inflammatory drugs (NSAIDs), and cyclosporine. Concomitant use of these medications may increase the risk of hyperkalemia or other adverse effects and should be carefully monitored.
Rank | Probiotic | Impact |
---|---|---|
species | Bifidobacterium longum | Reduces |
species | Escherichia coli | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Acne | 0.3 | -0.3 | |
ADHD | 1.3 | 0.1 | 12 |
Age-Related Macular Degeneration and Glaucoma | 0.1 | 0.1 | |
Allergic Rhinitis (Hay Fever) | 0.6 | 1 | -0.67 |
Allergies | 2.4 | 0.4 | 5 |
Allergy to milk products | 1.2 | 0.8 | 0.5 |
Alzheimer's disease | 1.4 | 1.3 | 0.08 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 1.3 | 1.1 | 0.18 |
Ankylosing spondylitis | 1.8 | 0.3 | 5 |
Anorexia Nervosa | 0.3 | -0.3 | |
Antiphospholipid syndrome (APS) | 0.9 | 0.9 | |
Asthma | 0.3 | 0.1 | 2 |
Atherosclerosis | 0.5 | 0.1 | 4 |
Atrial fibrillation | 0.8 | 0.9 | -0.13 |
Autism | 1.7 | 2.3 | -0.35 |
benign prostatic hyperplasia | 0.5 | 0.5 | |
Biofilm | 1 | 1 | |
Bipolar Disorder | 0.8 | 0.4 | 1 |
Brain Trauma | 0.3 | 0.1 | 2 |
Cancer (General) | 1.2 | -1.2 | |
Carcinoma | 1.1 | 0.6 | 0.83 |
Celiac Disease | 1 | 1.3 | -0.3 |
Cerebral Palsy | 0.3 | 0.3 | 0 |
Chronic Fatigue Syndrome | 2.3 | 0.9 | 1.56 |
Chronic Kidney Disease | 0.6 | 0.2 | 2 |
Chronic Lyme | 0.1 | -0.1 | |
Chronic Obstructive Pulmonary Disease (COPD) | 0.2 | -0.2 | |
Chronic Urticaria (Hives) | 1.4 | 0.3 | 3.67 |
Coagulation / Micro clot triggering bacteria | 1.4 | 0.2 | 6 |
Colorectal Cancer | 2.4 | 0.3 | 7 |
Constipation | 0.6 | 0.1 | 5 |
Coronary artery disease | 0.2 | 0.1 | 1 |
COVID-19 | 2.7 | 1.2 | 1.25 |
Crohn's Disease | 2.6 | 1.2 | 1.17 |
cystic fibrosis | 1.4 | 0.5 | 1.8 |
deep vein thrombosis | 1.4 | 0.2 | 6 |
Depression | 2.6 | 2.6 | 0 |
Dermatomyositis | 0.3 | -0.3 | |
Eczema | 0.5 | 0.7 | -0.4 |
Endometriosis | 2 | 0.2 | 9 |
Epilepsy | 1.2 | 0.4 | 2 |
Fibromyalgia | 0.1 | 0.7 | -6 |
Functional constipation / chronic idiopathic constipation | 3.1 | 1 | 2.1 |
gallstone disease (gsd) | 0.7 | 0.4 | 0.75 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.3 | 0.3 | |
Generalized anxiety disorder | 1.4 | 1.2 | 0.17 |
Gout | 0.1 | -0.1 | |
Graves' disease | 0.4 | 0.1 | 3 |
Halitosis | 0.1 | 0.1 | |
Hashimoto's thyroiditis | 0.5 | 0.4 | 0.25 |
High Histamine/low DAO | 1 | 0.5 | 1 |
hyperglycemia | 0.5 | 0.4 | 0.25 |
Hyperlipidemia (High Blood Fats) | 0.3 | 0.3 | |
hypertension (High Blood Pressure | 1.1 | 1.7 | -0.55 |
Hypothyroidism | 0.5 | -0.5 | |
Hypoxia | 0.1 | 0.1 | |
IgA nephropathy (IgAN) | 0.4 | -0.4 | |
Inflammatory Bowel Disease | 2.2 | 2.2 | 0 |
Insomnia | 0.1 | 0.2 | -1 |
Intelligence | 0.1 | 0.1 | |
Intracranial aneurysms | 0.3 | 0.3 | |
Irritable Bowel Syndrome | 2.1 | 0.5 | 3.2 |
Liver Cirrhosis | 1.3 | 0.8 | 0.63 |
Long COVID | 1.2 | 1.9 | -0.58 |
Low bone mineral density | 0.2 | -0.2 | |
Lung Cancer | 0.5 | 0.2 | 1.5 |
Mast Cell Issues / mastitis | 0.5 | 0.7 | -0.4 |
ME/CFS with IBS | 0.7 | -0.7 | |
ME/CFS without IBS | 0.1 | 0.4 | -3 |
Menopause | 0.7 | 0.7 | |
Metabolic Syndrome | 2.6 | 2.1 | 0.24 |
Mood Disorders | 3 | 2.6 | 0.15 |
Multiple Sclerosis | 1.2 | 0.7 | 0.71 |
Multiple system atrophy (MSA) | 0.1 | 0.5 | -4 |
neuropathic pain | 0.4 | -0.4 | |
Neuropathy (all types) | 0.5 | -0.5 | |
neuropsychiatric disorders (PANDAS, PANS) | 0.9 | 0.9 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.5 | 1.4 | -1.8 |
NonCeliac Gluten Sensitivity | 0.3 | 0.4 | -0.33 |
Obesity | 1.4 | 1.1 | 0.27 |
obsessive-compulsive disorder | 2.7 | 0.6 | 3.5 |
Osteoarthritis | 0.6 | 0.2 | 2 |
Osteoporosis | 0.8 | 0.1 | 7 |
Parkinson's Disease | 2.5 | 1.5 | 0.67 |
Polycystic ovary syndrome | 0.8 | 0.8 | 0 |
Postural orthostatic tachycardia syndrome | 0.5 | -0.5 | |
Premenstrual dysphoric disorder | 0.3 | 0.3 | |
Psoriasis | 1.8 | 0.3 | 5 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 1.3 | 1 | 0.3 |
Rosacea | 0.5 | 0.1 | 4 |
Schizophrenia | 1.4 | 0.7 | 1 |
scoliosis | 0.1 | 0.2 | -1 |
Sjögren syndrome | 0.5 | 0.4 | 0.25 |
Sleep Apnea | 0.7 | 0.3 | 1.33 |
Slow gastric motility / Gastroparesis | 1.2 | 0.3 | 3 |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.9 | 0.7 | 0.29 |
Stress / posttraumatic stress disorder | 1.4 | 0.6 | 1.33 |
Systemic Lupus Erythematosus | 1.1 | 0.6 | 0.83 |
Tic Disorder | 0.2 | 0.3 | -0.5 |
Tourette syndrome | 0.1 | -0.1 | |
Type 1 Diabetes | 1.3 | 0.1 | 12 |
Type 2 Diabetes | 2.6 | 2.3 | 0.13 |
Ulcerative colitis | 2 | 0.7 | 1.86 |
Unhealthy Ageing | 1 | 0.5 | 1 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results. i > p >
Explanations / Info / Descriptions are influenced by < a href = "/home/sources" target = "_blank" > Large Language Models a > and may not be accurate and include some hallucinations em >.Please report any to us for correction.
Copyright 2016 - 2024 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription
All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions / Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [44.222.131 ]
Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [44.222.131 ]